A community pharmacy-based cardiovascular screening service: views of service users and the public.

作者: Julia Taylor , Janet Krska , Adam Mackridge

DOI: 10.1111/J.2042-7174.2012.00190.X

关键词: ConfidentialityService (business)Family medicineMass screeningPublic healthNursingClinical pharmacyPopulationPharmacyRisk factorMedicine

摘要: Objectives  To determine whether pharmacy-based cardiovascular disease (CVD) screening reached the desired population, local population's awareness of pharmacy and views service users general public about CVD screening. Methods  Pharmacy staff, located in one English Primary Care Trust providing a service, issued questionnaires to who had undergone screening. Face-to-face street surveys were conducted with members within vicinity each participating pharmacy. Key findings  A total 259 people screened first 6 months provision, 97 whom (37.4%) completed evaluation questionnaire. In addition, 261 non-service participated surveys. Most respondents among both non-users at least risk factor for disease, including smoking lack exercise. Responses statements regarding showed high level agreement need groups. However, significantly more (90.7%) agreed that was good place compared (77.4%; P < 0.005). Likewise fewer should be only carried out by doctors (10.3 25.3% non-users; The overall majority 96 (99.7%) positive experience agreeing they given enough time pharmacists made them feel ease. Only 9% aware and, although (78.4%) willing pharmacy, this lower males than females (69.9 82.7%; Perceived concerns confidentiality privacy barriers identified taking up screening. Conclusion  Pharmacy-based is acceptable public. Its uptake could improved through increased addressing promotional activities.

参考文章(15)
Steven Allender, Mike Rayner, Asha Kaur, Peter Scarborough, Vito Peto, Coronary heart disease statistics. British Heart Foundation & Stroke Association. ,(2008)
Charles W. Morecroft, Janet Krska, Views of the general public on the role of pharmacy in public health Journal of Pharmaceutical Health Services Research. ,vol. 1, pp. 33- 38 ,(2010) , 10.1211/JPHSR.01.01.0013
G. M. Peterson, S. L. Jackson, J. D. Hughes, K. D. Fitzmaurice, L. E. Murphy, Public perceptions of the role of Australian pharmacists in cardiovascular disease Journal of Clinical Pharmacy and Therapeutics. ,vol. 35, pp. 671- 677 ,(2010) , 10.1111/J.1365-2710.2009.01139.X
Yifei Liu, Leslie J. Mentele, Randal P. McDonough, Kara M. Carruthers, William R. Doucette, Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents. Journal of The American Pharmacists Association. ,vol. 48, pp. 515- 517 ,(2008) , 10.1331/JAPHA.2008.07099
RUTH TEH, TIMOTHY CHEN, INES KRASS, Consumer perspectives of pharmacist‐delivered healtn information and screening services International Journal of Pharmacy Practice. ,vol. 9, pp. 261- 267 ,(2011) , 10.1111/J.2042-7174.2001.TB01057.X
Elizabeth J John, Theresa Vavra, Karen Farris, Jay Currie, William Doucette, Brenna Button-Neumann, Matt Osterhaus, Patty Kumbera, Tom Halterman, Tammy Bullock, Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight. Pharmacotherapy. ,vol. 26, pp. 1511- 1517 ,(2006) , 10.1592/PHCO.26.10.1511
Parastou Donyai, Melandi Van den Berg, Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service. Pharmacy World & Science. ,vol. 31, pp. 643- 647 ,(2009) , 10.1007/S11096-009-9338-4